A photo of Eileen King.

Professor, UC Department of Pediatrics



Biography & Affiliation


Dr. King provides leadership to administrative and data coordinating centers in the areas of congenital heart disease and pediatric obesity. Dr. King is highly involved in multi-institutional and multi-disciplinary clinical research studies and provides biostatistical leadership in the design, analysis, interpretation, and reporting of research results . She has industry experience in drug discovery, early and late stage drug development, commercialization, and market support for pharmaceutical products and has provided statistical leadership for regulatory interactions and submissions.

Dr. King is a fellow of the American Statistical Association (ASA) and has served on the board of directors. She has held leadership positions for the Council of Sections Governing Board and the Advisory Committee for Continuing Education in the ASA. She served as associate editor for the Journal of Statistical Education and statistical reviewer for scientific journals. Dr. King mentors junior faculty, staff and students in DBE and the Cincinnati Children's Hospital Medical Center Heart Institute. She is the primary instructor of “Statistical Principles for Clinical Research Studies” in the UC College of Pharmacy.

Research Interests

Clinical trials; data coordinating centers; data management; cardiac; pediatric obesity; gastrointestinal; health learning networks

Academic Affiliation

Professor, UC Department of Pediatrics



Blog Posts


BS: Regis College, Weston, MA, 1976.

MS: University of Wyoming, Laramie, WY, 1980.

PhD: Texas A&M University, College Station, TX, 1988.


Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy: a multicenter retrospective cohort study. Gorga, SM; Sahay, RD; Askenazi, DJ; Bridges, BC; Cooper, DS; Paden, ML; Zappitelli, M; Gist, KM; Gien, J; Basu, RK; et al. Pediatric Nephrology. 2020; 35:871-882.

Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial. Woodle, ES; Kaufman, DB; Shields, AR; Leone, J; Matas, A; Wiseman, A; West-Thielke, P; Sa, T; King, EC; Alloway, RR; et al. American Journal of Transplantation. 2020; 20:1039-1055.

Elucidation of de novo small insertion/deletion biology with parent-of-origin phasing. Seiden, AH; Richter, F; Patel, N; Rodriguez, OL; Deikus, G; Shah, H; Smith, M; Roberts, A; King, EC; Sebra, RP; et al. Human Mutation. 2020; 41:800-806.

Acute kidney injury, fluid overload, and outcomes in children supported with extracorporeal membrane oxygenation for a respiratory indication. Mallory, PP; Selewski, DT; Askenazi, DJ; Cooper, DS; Fleming, GM; Paden, ML; Murphy, L; Sahay, R; King, E; Zappitelli, M; et al. ASAIO Journal. 2020; 66:319-326.

Reply to Letter to the Editor by Frank Nice. Nommsen-Rivers, L; King, E; Wagner, E; Riddle, S; Ward, L; Thompson, A. Journal of Human Lactation. 2020; 36:196-196.

Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Aceves, S; Collins, MH; Rothenberg, ME; Furuta, GT; Gonsalves, N; Abonia, JP; Almonte, S; Andrews, R; Arrington, A; Arva, N; et al. Journal of Allergy and Clinical Immunology. 2020; 145:28-37.

Implementing a Novel Quality Improvement-Based Approach to Data Quality Monitoring and Enhancement in a Multipurpose Clinical Registry. Pratt, J; Jeffers, D; King, EC; Kappelman, MD; Collins, J; Margolis, P; Baron, H; Bass, JA; Bassett, MD; Beasley, GL; et al. eGEMs. 2019; 7.

Elevated serum complement levels and higher gene copy number of complement C4B are associated with hypertension and effective response to statin therapy in childhood-onset systemic lupus erythematosus (SLE). Mulvihill, E; Ardoin, S; Thompson, SD; Zhou, B; Yu, GR; King, E; Singer, N; Levy, DM; Brunner, H; Wu, YL; et al. Lupus Science and Medicine. 2019; 6:e000333-e000333.

Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: Establishing baseline values. Leino, AD; King, EC; Jiang, W; Vinks, AA; Klawitter, J; Christians, U; Woodle, ES; Alloway, RR; Rohan, JM. American Journal of Transplantation. 2019; 19:1410-1420.

Feasibility and Acceptability of Metformin to Augment Low Milk Supply: A Pilot Randomized Controlled Trial. Nommsen-Rivers, L; Thompson, A; Riddle, S; Ward, L; Wagner, E; King, E. Journal of Human Lactation. 2019; 35:261-271.